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ABSTRACT
BRCA2 is a key breast cancer associated protein that
is predicted to have interspersed regions of intrinsic
disorder. Intrinsic disorder coupled with large size
likely allows BRCA2 to sample a broad range of con-
formational space. We expect that the resulting dy-
namic arrangements of BRCA2 domains are a func-
tionally important aspect of its role in homologous
recombination DNA repair. To determine the archi-
tectural organization and the associated conforma-
tional landscape of BRCA2, we used scanning force
microscopy based single molecule analyses to map
the flexible regions of the protein and characterize
which regions influence oligomerization. We show
that the N- and the C-terminal regions are the main
flexible regions. Both of these regions also influence
BRCA2 oligomerization and interaction with RAD51.
In the central Brc repeat region, Brc 1–4 and Brc 5–8
contribute synergistically to BRCA2 interaction with
RAD51. We also analysed several single amino acid
changes that are potentially clinically relevant and
found one, the variant of F1524V, which disrupts key
interactions and alters the conformational landscape
of the protein. We describe the overall conformation
spectrum of BRCA2, which suggests that dynamic
structural transitions are key features of its biologi-
cal function, maintaining genomic stability.
INTRODUCTION
Almost 80% of the proteins associated with human cancer
are predicted to have intrinsically disordered regions (IDRs)
of >30 amino-acids (1). Despite their ubiquity, the precise
functional contribution of intrinsic disorder in these pro-
teins has not been determined. IDRs participate in weak
and transient but specific interactions facilitated by a con-
formational repertoire (2). Therefore, to understand the
functional spectrum of such proteins it is important to map
and define their conformational landscape.
BRCA2 is an essential protein with a well-defined role in
the error-free repair of double-strand DNA breaks by ho-
mologous recombination repair (3,4). The best elucidated
function of BRCA2 is to deliver the DNA strand exchange
protein RAD51 to the site of DNA damage to facilitate
repair (5,6). BRCA2 interacts with RAD51 primarily via
the Brc repeat region that forms the middle one-third of
the protein (Figure 1). The eight Brc repeats can each bind
RAD51 and are reported to function in a modular fash-
ion with different roles for Brc 1–4 and Brc 5–8. The two
modules have been reported to have different affinities for
RAD51, ranging between 1–2 M (Brc 1, 2, 4) and 100–200
M (Brc 6, 7 and 8) (7). The isolated modules are biochem-
ically distinct with respect to the RAD51 forms they bind
(monomers or filament polymers), their differential inhibi-
tion of DNA-dependent ATPase activity of RAD51, and
their effects on RAD51-mediated DNA strand exchange
in vitro (7–13). Each Brc repeat comprise about 35 aa in-
cluding highly conserved tetra amino acid motifs of FxxA
and LFxD/E, which are crucial for BRCA2–RAD51 in-
teraction (10,14). This interaction is structurally well char-
acterized in these isolated regions and assumed to repre-
sent the interaction in the full-length protein. In crystal
structure of Brc 4 and RecA-homology domain of RAD51,
residues F1524 to V1532 in Brc 4 form a -hairpin with
the F1524 being buried in a hydrophobic pocket formed
by RAD51 (9). BRCA2 is also reported to interact with
RAD51 through the C-terminal region, where phosphory-
lation of BRCA2 S3291 by cyclin-dependent kinases reg-
ulates RAD51 interaction and recombinase activity in the
cell-cycle (15,16).
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Figure 1. Schematic overview of the BRCA2 regions studied. (A) Different regions of fl-BRCA2 produced for this study. (B) Variants of unknown clinical
significance produced for this study.
BRCA2 is predicted to have multiple stretches of intrin-
sic disorder interspersed along its 3418 amino acids (17).
Some regions of the protein have defined structures, at least
in complex with binding partners. The N-terminal aa 21–39,
Brc 4 (aa 1517–1551) and the C-terminal region (mouse aa
2378–3114) have been crystallized in complex with parts of
their binding partners, PALB2, RAD51 and DSS1 + single-
stranded DNA, respectively. The crystal structure of the
N-terminal region and Brc 4 adopts short stretches of -
helix and -hairpin (9,18). The C-terminus folds in distinct
domains; the helical domain (aa 2481–2668), the oligonu-
cleotide binding domains (aa 2670–3185) and the tower
domain (aa 2838–2962) (19). Although providing detailed
structures for these regions of BRCA2, the isolated struc-
tures do not indicate how these regions are arranged in
the full-length protein. Two major challenges in studying
full-length BRCA2 (fl-BRCA2) are its size and abundant
IDRs.
IDRs are typically associated with structural variability
or flexibility, which is incompatible with methods that re-
quire a sample with uniform molecular structure (X-ray,
NMR, EM reconstruction). In contrast, quantifying the
distribution of forms in a conformational ensemble can
provide unique insight into flexibility and the influence of
protein-protein and protein–DNA interactions (17,20–25).
IDRs allow protein molecules to act as dynamic confor-
mational switches, sensitive to interaction with other pro-
teins, environmental changes and post-translational modifi-
cations (2,26). We have previously characterized the confor-
mational variability of fl-BRCA2 by single molecule scan-
ning force microscopy (SFM) imaging (17). BRCA2 is ob-
served to be a mixture of multimeric forms which were ex-
tended and apparently flexible molecules, or compact and
globular, depending on the temperature of incubation and
presence of binding partners. BRCA2 appears as a flexible
molecule that switched conformation in response to tem-
perature change from 37 to 0◦C. Incubation of BRCA2
with RAD51 results in a compact elongated conformation,
which can include multiple BRCA2 and RAD51 molecules
per complex (17). Major changes in oligomerization of fl-
BRCA2, from large oligomers to monomers, have also been
reported by Le et al. on complexation with DSS1 and ss-
DNA (25). Thereby, highlighting the diverse conforma-
tional landscape of BRCA2 in protein-protein and protein–
DNA interactions.
Here, we probe the contribution of different regions of
BRCA2 to its conformational landscape by SFM. The N-
and the C-terminal regions of BRCA2 are the most vari-
able in structure, presumably due to flexibility. The cen-
tral region including the Brc repeats appears to be involved
in oligomerization, both self-association, BRCA2–BRCA2,
and in BRCA2–RAD51 complexes. In agreement with pre-
vious studies, we show that in isolation the two Brc modules
(1–4 and 5–8) are biochemically distinct. However, in the
context of the whole protein the two modules contribute
synergistically to the conformational landscape. We simi-
larly analysed the architectural effects of two clinically rel-
evant missense variants of the Brc region in detail, F1524V
and G1771D. The single amino acid change F1524V in Brc
4 had a dramatic effect on BRCA2 conformational land-
scape and interaction with RAD51. These results highlight






/nar/article/48/17/9649/5891569 by guest on 05 M
arch 2021
Nucleic Acids Research, 2020, Vol. 48, No. 17 9651
bution of disordered proteins to identify factors that can
affect their conformation and function.
MATERIALS AND METHODS
Protein expression and purification
Regions of BRCA2 (N region, R region, C region, NR re-
gion, RC region, BRCA2 Brc 1–4, BRCA2 Brc 5–8,
Brc 1–4 and Brc 5–8), with two tandem N-terminal mal-
tose binding protein (MBP) tag, and BRCA2 variants of
unknown significance (BRCA2F1524V, BRCA2G1771D) were
made by Q5® site directed mutagenesis (NEB) (Figure 1)
(Plasmid for fl-BRCA2 gene was kindly gifted by S. Kowal-
czykowski). Positive clones for each variant were sequence
verified. Proteins for temperature studies were purified ac-
cording to protocol as described elsewhere (3), from plate
cultures. For other studies, purified plasmids were trans-
fected with 10% (v/v) transfection solution in 293T HEK
cells, adapted for suspension culture, in FreeStyle™ 293 Ex-
pression Medium (Gibco) at approximately 106 cells/ml.
Transfection solution was prepared by adding 1 g/ml pu-
rified DNA and 2 g/ml linear PEI in Serum-Free Hy-
bridoma Media (Gibco®) supplemented with 1% FCS.
Transfection solution was incubated for 20 min at room
temperature and added to 500 ml or 1 l of HEK cell sus-
pension growing at 37◦C with shaking at 250 rpm. Except
for cell cultures with the BRCA2 Brc 1–4 construct, which
showed highest number of cells 24 h post transfection, cells
with all other constructs were harvested after 48 h, at a cell
count of about 2 × 106 cells/ml, by centrifugation at 8000
× g at 4◦C for 15 min. The cell pellet was resuspended in
10 ml ice cold PBS and frozen in liquid nitrogen. Next, cells
were lysed in 200 ml lysis buffer (50 mM HEPES pH 7.5,
250 mM NaCl, 1% NP-40, 1 mM ATP, 3 mM MgCl2, 1
mM Pefabloc SC [Merck], two tablets EDTA free protease
inhibitor [Roche], 1 mM DTT) for 15 min at 4◦C with shak-
ing. The lysate was centrifuged at 10 000 × g at 4◦C for 15
min. The supernatant was incubated overnight with 6 ml
Amylose resin (NEB) pre-equilibrated in wash buffer (50
mM HEPES pH 7.5, 250 mM NaCl, 0.5 mM EDTA and
1 mM DTT). The next day, the beads were washed three
times with wash buffer by centrifugation at 2000 × g at 4◦C
for 5 min and aspiration of the supernatant. The washed
resin was incubated with elution buffer (50 mM maltose,
50 mM HEPES pH 8.2, 250 mM NaCl, 0.5 mM EDTA,
10% glycerol, 1 mM DTT, 1 mM Pefabloc SC) for 15 min at
4◦C on a rolling platform. The eluate was collected by pass-
ing the slurry through a disposable BioRad column at 4◦C.
The eluate was loaded on a 1 ml HiTrap Q column (GE)
using Q low buffer (50 mM HEPES pH 8.2, 250 mM NaCl,
0.5 mM EDTA, 10% glycerol, 1 mM DTT, 1 mM PMSF)
and eluted with Q high buffer (50 mM HEPES pH 8.2, 1
M NaCl, 0.5 mM EDTA, 10% glycerol, 1 mM DTT, 1 mM
PMSF). Fractions with proteins were aliquoted into single
use aliquots, which were then snap frozen in liquid nitrogen
and were stored at −80◦C. Yield of protein purification, esti-
mated by CBR-250 stained PAGE gels with BSA standards,
was between 2 and 4 g per preparation for all the regions
(Supplementary Figure S1).
Purification at various steps was assessed by west-
ern blot using anti-BRCA2 antibodies. For N region,
BRCA2 Brc 5–8 and BRCA2G1771D, rabbit polyclonal
anti-BRCA2 (1:1000) (3675-Biovision) was used as the
primary antibody followed by donkey anti-rabbit HRP
(1:2500) (Jackson ImmunoResearch) as the secondary an-
tibody. For R, NR, RC, BRCA2 Brc 1–4, BRCA2F1524V,
mouse monoclonal anti-BRCA2, epitope aa 1651–1821 (1:
500) (OP95-Calbiochem®) was used as the primary an-
tibody and sheep anti-mouse HRP (1:2000) (Jackson Im-
munoResearch) as the secondary antibody. For C, rab-
bit polyclonal anti-BRCA2, epitope aa 3245–3418 (1:500)
(CA1033-Calbiochem®) was used as the primary antibody
followed by donkey anti-rabbit HRP (1:2500) (Jackson Im-
munoResearch) as the secondary antibody. For Brc 1–4, Brc
5–8, rabbit polyclonal anti-maltose binding protein (1:2000)
(ab9084-abcam) was used as the primary antibody and don-
key anti-rabbit HRP (1:2500) (Jackson ImmunoResearch)
as the secondary antibody (Supplementary Figure S2).
Untagged human RAD51 was expressed and purified as
described (21).
SFM sample preparation, imaging and analyses
Flexibility of BRCA2 regions. Aliquots of BRCA2 regions
were thawed and diluted four-fold in 10 mM HEPES pH
8.2 buffer to prepare a reaction of 10 nM BRCA2 variant in
22 mM HEPES pH 8.2, 112 mM NaCl, 0.125 mM EDTA,
2.5% glycerol, 0.25 mM DTT. Samples were incubated at
37◦C or 0◦C (on ice) for 30 min without shaking.
BRCA2 variants–RAD51 interaction. For BRCA2–
RAD51 reactions, the diluted samples, as above, were
incubated at 37◦C in the absence or presence of 250 nM
RAD51 for 30 min without shaking.
SFM imaging. Samples for SFM imaging were prepared
by depositing 20 l reaction on a freshly cleaved mica (Mus-
covite mica, V5 quality, EMS) for 2 min, followed by a 2 ml
wash using 18 M water and drying in filtered (0.22 m)
air. SFM images were scanned on a Nanoscope VIII scan-
ner (Bruker), using tapping mode in air with a silicon probe,
NHC-W, with tip radius <10 nm and resonance frequency
range of 310–372 kHz (Nanosensor, Veeco Instruments, Eu-
rope). All images were acquired with a scan size of 2 × 2 m
at 512 × 512 pixels per image at 1 Hz. Images were processed
using Nanoscope analysis (Bruker) for background flatten-
ing. Quantitative analyses of images was performed as de-
scribed using SFMetrics software (27). Briefly, molecules
from flattened SFM images were selected in the multimode
image analysis mode of SFMetrics and thresholded to cal-
culate volume, as the product of the average height and area.
The molecular volume has been shown to linearly co-relate
with the molecular mass of biomolecules in SFM height im-
ages (28). Thus, based on volume, the oligomeric state of
the select molecule can be calculated. Escherichia coli RNA
polymerase (RNAP), with a molecular mass of 450 kDa and
volume of 678 nm3, was used as a reference to determine the
volume of one 2MBP-BRCA2 molecule (17). At 469 kDa, a
monomer of 2MBP-fl-BRCA2 is equivalent to 1.04 RNAP
or 707 nm3. Volume less than half of monomer volume was
used as a cut-off to threshold lower molecular mass species.
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as monomer and so on. Monomer volume of each of the
region was calculated similarly.
Volume of BRCA2–RAD51 complex depends on the or-
ganization of the complex and can be calculated assuming
three possible arrangements. (i) Additive volume, if RAD51
molecules dock on the surface of BRCA2, the resultant
volume of the complex will be the volume of 1 BRCA2 +
nRAD51. (ii) BRCA2 volume, if RAD51 occupies a void
inside a large complex it will not contribute to the envelope
volume measured by SFM and would thus be equivalent to
BRCA2 volume. (iii) Range between BRCA2 volume and
additive volume, if RAD51 interaction induces reorganiza-
tion of BRCA2 then the volume of the complex can range
between monomer volume of BRCA2 to the additive vol-
ume. In SFM experiments we observe a change in confor-
mation of BRCA2 on interaction with RAD51 and thus sce-
nario 3 is the closest assumption for BRCA2–RAD51 com-
plex. Purified fl-BRCA2 binds 6 RAD51 monomers in con-
ditions similar to those applied here (3). A BRCA2-RAD51
complex with one BRCA2 (707 nm3) and six RAD51
(56 × 6 = 336 nm3) can have maximum volume of 1043
nm3, which falls within the range of monomer volume for
BRCA2 (353–1060 nm3). Thus, in samples with BRCA2–
RAD51 complex, monomer volume of BRCA2 was used for
quantitation, with half monomer volume of BRCA2 as the
threshold. For different regions of BRCA2 under study, us-
ing similar approach, monomer volume of BRCA2-region:
nRAD51 complex can include one BRCA2 region with 2–5
RAD51 molecules (see Supplementary Table S1 for more
details). Oligomeric volume of the different regions was
calculated similarly. At 56 nm3 the monomer volume of
RAD51 is much lower than the threshold volume and thus
free RAD51 is removed from analysis (Supplementary Fig-
ure S3).
The conformation of the molecules was quantified by the
parameters of solidity. Solidity is the ratio of the area of
an object to the area of a convex hull that completely en-
closes the object. Solidity in a scale of 1 to 0 quantifies the
globularity (S ∼ 1) and irregularity (S ∼ 0) of a molecular
shape. Change in solidity provides a quantitative readout
for change in the shape of a molecule and is independent of
its size.
RESULTS
To determine which parts of BRCA2 contribute to the ob-
served conformational flexibility in vitro, we cloned, ex-
pressed and purified five regions of BRCA2 (Figure 1A
and Supplementary Figure S1). Three regions, N-terminal
(N: aa 1–939), Brc Repeat region (R: aa 940–2130) and C-
terminal (C: aa 2131–3418), which span the length of the
protein without sequence overlap. Two regions, N-terminal-
Repeat region (NR: aa 1–2130) and Brc Repeat region-C-
terminal (RC: aa 940–3418) both include the Brc repeat re-
gion in combination with either the N- or C-terminus, each
representing about two thirds of the full-length protein. We
analysed the different regions for their probability of intrin-
sic disorder with respect to fl-BRCA2 using web-based tool
IUPred2A. All the regions exhibited similar profile for in-
trinsic disorder, as fl-BRCA2, suggesting suboptimal pre-
diction of changes that are likely to arise due to deletion of
parts of BRCA2 (Supplementary Figure S4).
In single molecule conformation studies, we define molec-
ular architecture of BRCA2 assemblies with the parame-
ters: oligomerization and solidity. Oligomerization is de-
termined by volumetric analysis, in which measured vol-
ume and expected volume of a monomeric unit are used
to compute the oligomeric state of the molecule. Solidity
quantifies the shape of the molecule in a spectrum of globu-
lar (with solidity ∼1) to highly irregular (with solidity ∼0).
The conformational landscape is represented in the distri-
bution of these forms in a population and changes in the
distribution.
Flexibility is most prominent for BRCA2 N- and C-terminal
regions
Purified proteins were imaged after incubation at 37 and
0◦C and the images were analysed for oligomerization and
solidity (17,27). In SFM images, all the proteins appeared
as complexes of irregular size at 37◦C with fl-BRCA2 also
showing irregularity in shape with prominent extensions
(Figure 2A: 37◦C). BRCA2 molecules incubated at 0◦C, be-
fore deposition, were more compact and globular (Figure
2A: fl-BRCA2 panel). The distribution of molecules with
varying solidity showed a definitive shift towards higher so-
lidity (∼0.9) i.e., more globular at lower temperature (37
versus 0◦C) (Figure 2B: fl-BRCA2 panel). Similar to fl-
BRCA2, all the regions including the N- or C-terminus (N,
C, NR and RC) changed conformation with temperature
(Figure 2A, B). The R region alone did not change in con-
formation with temperature (Figure 2A, B: panels labelled
R). RC like fl-BRCA2 was more compact (distribution shift-
ing toward higher solidity) at lower temperature (0◦C) while
the N, C and NR became more extended and irregular (dis-
tribution shifted toward lower solidity) (Figure 2B). This
opposite change in molecular conformation in different re-
gions with temperature, is likely a complex phenomenon,
which has been observed in earlier temperature dependent
studies in disordered proteins but is not fully understood
(29–31).
The distribution of oligomeric states for fl-BRCA2 and
the RC region did not change with temperature, suggest-
ing that the same size complex became more compact (Fig-
ure 2C and Supplementary Table S2). This more compact
conformation for fl-BRCA2 and RC likely represents lower
conformational entropy at 0◦C (32,33). Correspondingly,
the absence of change in distribution of forms in the R re-
gion (Figure 2B and C and Supplementary Table S2) in-
dicates low flexibility, more ordered structure, including
inter/intra-molecular interactions among the eight Brc re-
peats that consequently allow less freedom to move. In-
creased irregularity of N and C regions, was accompanied
by higher oligomerization at lower temperatures (Figure 2C
and Supplementary Table S2), signifying that low tempera-
ture favours conformations that promoted oligomerization.
The NR variant was more irregular at lower temperatures
together with a slight decrease in larger oligomeric forms
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Figure 2. The N- and C-terminal regions of BRCA2 provide flexibility to fl-BRCA2. (A) Representative SFM height images showing change in confor-
mation of fl-BRCA2 and the different regions at 37 and 0◦C. The representative images do not necessarily depict the most populous molecular assemblies
but are aimed to show, as much as is possible in a single image, the range of architecture of BRCA2 constructs. Note: The Z-scale in some of the images
is different to allow optimal visualization of molecules. (B) Histograms showing change in solidity, readout for conformational flexibility, of the BRCA2
regions with temperature, at 37 and 0◦C. Histograms for solidity were normalised to their maximum value. (C) Oligomeric distribution of the BRCA2
regions at 37 and 0◦C.
tion (Figure 2B and C, Supplementary Table S2). All pro-
teins including the N region (N, NR and fl-BRCA2) showed
a change in conformation with temperature and a relatively
broad spread in conformational distribution (Figure 2B: so-
lidity) indicating that the N region is the most flexible part
of BRCA2, followed by the C region.
All regions of BRCA2 can interact with RAD51
Extended fl-BRCA2 adopts a characteristic compact and
elongated conformation on interaction with RAD51 (17).
These compact assemblies, formed at a molar ratio of 1:24
(BRCA2:RAD51) and cross-linked by glutaraldehyde, were
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RAD51 molecules per complex (17). To dissect the contri-
bution of different regions of BRCA2 to this transition we
determined the effect of RAD51 on conformational land-
scape of the five BRCA2 regions (N, R, C, NR and RC). In
order to reveal the multimeric state of the different regions
we did not fix the samples with glutaraldehyde in the present
study. In the absence of RAD51, 68% of the fl-BRCA2 was
present in irregular, oligomeric assemblies, whose volume
indicated complexes larger than tetramers (Figure 3A and
B, Supplementary Table S3). Fl-BRCA2 reorganized in the
presence of RAD51 into predominantly monomeric com-
plexes (75%) with compact conformation (Figure 3B and
C: fl-BRCA2+RAD51 and Supplementary Table S3).
Among the different regions, the isolated N (42%) and
C (41%) regions had the smallest percentage of larger
oligomers (Figure 3B, Supplementary Figure S5 and Sup-
plementary Table S3). BRCA2 parts including the R region,
R (59%), NR (74%) and RC (66%), showed most oligomeric
complexes in the size range larger than tetramers. On
incubation with RAD51, oligomers diminished and the
population shifted to majority monomer to dimer, N
(90%), C (63%) and NR (95%) (percent molecules here
= monomers + dimers) (monomer volume of BRCA2-
region: nRAD51 complex includes 1 BRCA2 region with
2–5 RAD51 molecules: for details see materials and meth-
ods: SFM imaging) (Figure 3, Supplementary Figure S5
and Supplementary Table S3). The R region also showed
a decrease in large oligomers (37 vs 59%) accompanied
by molecules reorganizing into tetramers (13%), trimers
(20%) and dimers (20%). The RC region showed the small-
est change in oligomerization with only ∼10% of large
oligomers shifted towards smaller assemblies (Figure 3,
Supplementary Figure S5 and Supplementary Table S3).
However, average solidity of RC complexes changed the
most from ∼0.9 to ∼1 on interaction with RAD51 (Fig-
ure 3C: RC). Thus, the RC region did rearrange most
likely from BRCA2–BRCA2 oligomers to BRCA2–RAD51
oligomers. In all the cases, incubation with RAD51 caused
an increase in monomer/dimer sized complexes and de-
crease in complexes larger than tetramers (Figure 3B).
Brc repeats behave differently in isolation versus as part of
BRCA2
Biochemically the eight Brc repeats are reported to have dif-
ferent affinities for RAD51 and function in two modules of
Brc 1–4 and Brc 5–8 (7,11). To determine the contribution
of these two modules of Brc repeats to oligomerization and
conformation of fl-BRCA2 we prepared regions with dele-
tion of Brc 1–4 (BRCA2 Brc 1–4, aa 940–1549) and Brc
5–8 (BRCA2 Brc 5–8, aa 1665–2130) along with com-
plementary fragments consisting only of the repeat regions
of Brc 1–4 (aa 940–1664) and Brc 5–8 (aa 1550–2130) (Fig-
ure 1A). These regions were incubated in the presence or ab-
sence of RAD51 and analysed for oligomerization (17,27).
Monomer volume of BRCA2-region:nRAD51 complex in-
cludes one BRCA2 region with 2–5 RAD51 molecules (for
details, see Materials and Methods: SFM imaging).
BRCA2 Brc 1–4 appeared as irregular multimeric as-
semblies with 79% of the molecules observed in clus-
ters larger than tetramers, similar to fl-BRCA2. Whereas
BRCA2 Brc 5–8, although also irregular, formed fewer
large oligomers with only 41% of complexes larger than
tetramers. In isolation Brc 5–8 was also predominantly
present as irregular multimeric assemblies, with 65% in
oligomers larger than tetramers, thus being similar to
BRCA2 Brc 1–4 (Figure 4 and Supplementary Table S4).
For both BRCA2 Brc 5–8 and Brc 1–4, a higher propor-
tion of the molecules were present in monomers. Therefore,
whether in isolation or in the background of the rest of
BRCA2, Brc 5–8 had a higher propensity to oligomerize
(Figure 4B; no RAD51 panel, S6 and Supplementary Ta-
ble S4).
On incubation with RAD51, all the Brc fragments
formed compact elongated structures (Figure 4A and Sup-
plementary Figure S7). Monomeric forms became the
most prominent species for both BRCA2 Brc 1-4-RAD51
(41%) and BRCA2 Brc 5-8-RAD51 (63%) (Figure 4B
and Supplementary Table S4). The isolated Brc repeats be-
haved differently. In the presence of RAD51, Brc 1–4 be-
came predominantly dimer-trimer (25%, 22%) with loss of
both monomers and large oligomers. Even in the presence
of RAD51 the most prominent form of Brc 5–8 was large
oligomers (39%). (Figure 4B and Supplementary Table S4).
This observation differs from distribution of molecules
without RAD51, where the major population in all the con-
structs was oligomers larger than tetramers. BRCA2 Brc
1–4 and BRCA2 Brc 5–8 changed the most from large as-
semblies to monomers. The Brc 1–4 and Brc 5–8 showed re-
organization into dimers, trimers and tetramers. Therefore,
on interaction with RAD51, the modules of Brc repeats
contribute to the oligomeric distribution differently. In iso-
lation they are more multimeric while in the BRCA2 pro-
tein they promote monomeric assemblies, as for fl-BRCA2.
Hence signifying that the contribution to conformational
transitions and oligomerization of the two Brc modules is
not independent but likely synergistic in the fl-BRCA2.
Single amino acid variation in F1524V alters conformational
landscape of BRCA2
Fragments covering relatively large regions of BRCA2wt in-
dicated their different contribution to the conformational
landscape of the protein. We were curious if any of the sin-
gle amino acid variants of unknown significance (VUS, of-
ten reported from breast cancer patient derived sequencing
studies, UniProtKB-P51587, BRCA2 HUMAN) could in-
fluence this conformational landscape. We screened a num-
ber of clinically relevant variants of BRCA2 and selected
two, F1524V and G1771D to probe their functional sig-
nificance in detail. The variations lie in the Brc repeat re-
gion and were identified in genetic screens from breast can-
cer patients (34,35). The choice of these variants was based
on two criteria, 1) the amino acid change is in the RAD51
interacting region of Brc repeats, and 2) the variation is
likely to perturb innate interactions of the BRCA2wt. In
BRCA2F1524V, the hydrophobic phenylalanine is replaced
by an aliphatic valine, predicted to destabilize Brc4-RAD51
interaction (36) and possibly altering a structural motif
due to different spatial geometry. In BRCA2G1771D, a small
aliphatic glycine is replaced by negatively charged bulkier
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Figure 3. All regions of BRCA2 interact with RAD51. (A) Representative SFM height images showing change in conformation of fl-BRCA2 and NR
region in the presence of RAD51, 37◦C. Green arrows highlight compact elongated assemblies in the presence of RAD51. The representative images do
not necessarily depict the most populous molecular assemblies but are aimed to show, as much as is possible in a single image, the range of architecture of
BRCA2 constructs. Note: The Z-scale in the images is different to allow optimal visualization of molecules. (B) Oligomeric distribution and (C) histogram
showing distribution of conformations for fl, N, R, C, NR, RC regions in the absence and presence of RAD51. Histograms for solidity were normalised to
their maximum value. Differences in conformation of fl-BRCA2 and regions between Figure 2 (37◦C) and Figure 3 (no RAD51) reflects variation between
protein preparation from plate and suspension culture and the corresponding yields (see Supplementary Figure S6 and accompanying note).
or steric hindrance. The variants were imaged in the pres-
ence and absence of RAD51 and analysed for oligomeriza-
tion and solidity.
Both the single amino acid variants, like BRCA2wt,
formed irregular multimeric assemblies (Figures 3A, 5A
and Supplementary Figure S8). In the absence of RAD51,
BRCA2F1524V and BRCA2G1771D were similar to BRCA2wt
with extended shape and average solidity at ∼0.8 (Fig-
ure 5C and Supplementary Table S5). With respect to
oligomerization, BRCA2F1524V deviated the most, consist-
ing of only 35% oligomers larger than tetramers versus 68%
for BRCA2wt and 63% for BRCA2G1771D (Figures 5B, Sup-
plementary Figure S8 and Supplementary Table S6). More-
over, the BRCA2F1524V variant had the highest proportion
of monomers at 28%, signifying a reduced ability to self-
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Figure 4. Brc repeats of BRCA2 contribute synergistically to the conformational landscape of the full-length protein. (A) Representative SFM height
images of BRCA2 Brc 1–4 (left panel) and Brc 5–8 (right panel) in the absence and presence of RAD51. Green arrows highlight compact elongated
assemblies in the presence of RAD51. The representative images do not necessarily depict the most populous molecular assemblies but are aimed to show,
as much as is possible in a single image, the range of architecture of BRCA2 constructs. Note: The Z-scale in the images is different to allow optimal
visualization of molecules. (B) Oligomeric distribution of fl, BRCA2 Brc 5–8, Brc 1–4, BRCA2 Brc 1–4 and Brc 5–8 in the absence (top panel) and
presence (bottom) of RAD51. Brc 1–4 and Brc 5–8 are controls for BRCA2 Brc 5–8 and BRCA2 Brc 1–4, respectively. Distinct oligomeric profiles of
the two groups, highlighted in red and grey rectangles, on interaction with RAD51 show that Brc 1–4 and Brc 5–8 are biochemically distinct in isolation.
The most notable conformational change of BRCA2wt
in our studies was upon interaction with RAD51. Particu-
larly, the large oligomers of BRCA2 reorganized into promi-
nent monomer population in the presence of RAD51. This
change was evident in BRCA2G1771D, where the distribution
of forms was similar to BRCA2wt where larger oligomers
diminished to redistribute mostly in monomers, dimers and
trimers. BRCA2F1524V however, showed almost no change
in oligomeric distribution in response to RAD51 (Figure
5B and Supplementary Table S6).
The conformational distribution for BRCA2G1771D was
similar to BRCA2wt, with average solidity of ∼1 in the
presence of RAD51. For BRCA2F1524V, although volume
distribution did not change, there was a change in con-
formation upon interacting with RAD51. This confor-
mational change however was also muted, compared to
BRCA2wt and BRCA2G1771D, displaying an average solidity
of ∼0.9 upon incubation with RAD51 (Figures 5A, Sup-
plementary Figure S8 and Supplementary Table S5). For
BRCA2F1524V about 30% of the molecules had solidity <0.9
while in BRCA2wt and BRCA2G1771D this was a negligi-
ble percentage, 1%, and 4% respectively. A notable num-
ber of BRCA2F1524V molecules in SFM images also dis-
played an extended conformation revealing lack of con-
formational change upon interaction with RAD51 (Figure
5A). The single amino acid change in the variant F1524V
had a large influence (equivalent to or greater than delet-
ing a region including Brc 1–4) on both self-oligomers of
BRCA2 and an impaired conformational switch on inter-
action with RAD51.
DISCUSSION
To understand how different parts of BRCA2 contribute to
its flexibility we prepared regions of BRCA2 and systemati-
cally quantified their conformational profile with respect to
solidity and oligomerization. Temperature induced changes
in the different regions, at 37 and 0◦C, indicated plasticity
and identified the N and C regions of BRCA2 as most flexi-
ble. All regions including either N- or C-terminal part (N, C,
NR and RC) changed conformation with temperature. The
temperature induced change in solidity distribution among
the smaller regions (N, C, NR and RC) was not as promi-
nent as for fl-BRCA2, probably due to their smaller size,
which were not as irregular or extended to begin with. The
observed low oligomerization of the N and C region along
with highly oligomeric assemblies of segments including the
R region is indicative of the importance of Brc repeat region
in BRCA2–BRCA2 interaction. The R region did not show
any temperature induced change. However, NR and RC did
change despite the presence of the Brc repeats demonstrat-
ing that the flexible N- and C-terminal regions can influ-
ence Brc repeat mediated self-oligomerization of BRCA2.
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Figure 5. Single amino acid variations in BRCA2wt can alter conformational landscape of the protein. (A) Representative SFM height image of
BRCA2F1524V in the absence (top panel) and presence (bottom panel) of RAD51. Green arrow highlights the persistence of flexible extended molecules in
the presence of RAD51. The representative images do not necessarily depict the most populous molecular assemblies but are aimed to show, as much as is
possible in a single image, the range of architecture of BRCA2 constructs. (B) Oligomeric distribution and (C) histogram of conformation for wt, F1524V
and G1771D in the absence and presence of RAD51. Histograms for solidity were normalised to their maximum value.
ways compared to the complete protein demonstrating in-
terdependence of different regions of BRCA2 for its overall
conformation.
Segments including the N region (fl, N, NR) became pre-
dominantly monomeric on interaction with RAD51 while C
region showed a peak population at monomers and dimers.
Therefore, C region also appears to be involved in oligomer-
ization, as indicated by prominent dimers + trimers in C-
RAD51 reactions, while N appears to promote monomer-
ization. The observations of change in self-oligomeric state
of BRCA2 on incubation with a binding partner is in agree-
ment with a recent report, where self-association of BRCA2
via the N and C regions was shown to be sensitive to BRCA2
interacting partners, DSS1 and ssDNA (25). The R and RC
regions even in the presence of RAD51 were mostly larger
oligomers, reaffirming the role of the R region in oligomer-
ization. The discrete pattern of interaction of different re-
gions of BRCA2 on interaction with RAD51 is suggestive
of specific functional role, most likely either in a cascade of
reactions or via dynamic allostery (2,37,38).
The two Brc modules, Brc 5–8 and Brc 1–4, also had dis-
tinct oligomeric profiles in the presence of RAD51. These
modules are biochemically different with respect to their
potential for free RAD51 binding, inhibition of DNA-
dependent ATPase activity of RAD51 and RAD51 medi-
ated DNA strand exchange reaction (7,11). Data from GST
pull-down assays by Carreira et al. indicate very weak affin-
ity of Brc 5–8, in the range of 100–200 M, for free RAD51
(7). We observed here that Brc 5–8 reproducibly showed
significant reorganization in the presence of RAD51, sug-
gesting that RAD51 induced reorganization of BRCA2
oligomers does not require very strong affinity. Deletion
of either repeat module, for example in BRCA2 Brc 1–
4 which retains the Brc 5–8 module, resulted in a protein
with oligomeric forms more like fl-BRCA2–RAD51 than
like Brc 5-8-RAD51. In the context of fl-BRCA2, the be-
haviour of Brc 1–4 and Brc 5–8 is not the sum of their be-
haviour in isolation but rather they exhibit synergistic be-
haviour, a characteristic of IDPs, where different parts of a
protein cross-talk to define the conformational landscape of
the whole molecule.
In addition to the R region, the N and the C region
also show conformational transition on incubation with
RAD51. While there is a reported phosphorylation de-
pendent binding site for RAD51 in the C-terminal region
(15), the N-terminal regions is not known to interact with
RAD51 (11). The eight Brc repeats have highly conserved
tetra amino acid motifs of FxxA, FxxG and xFxE that are
reported to be key for RAD51 interaction (10,14). A se-
quence search of BRCA2 for potential FxxA, FxxG and
xFxE motifs revealed that the N- and the C-terminal re-
gion also have a number of these potential RAD51 interac-
tion motifs (Supplementary Table S7). However, being very
short motifs, only four amino acids, they are likely to be de-
generate and their mere presence is not sufficient to explain
the observed conformational changes. Further systematic
conformational and biochemical experiments are needed to
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For more specific information on BRCA2 conforma-
tional flexibility we analysed two clinically identified vari-
ants of BRCA2, BRCA2F1524V, BRCA2G1771D, both located
in the Brc repeats (34,35). The single amino acid change
BRCA2F1524V, in the Brc 4 repeat, drastically impaired the
characteristic conformational change of BRCA2 on inter-
action with RAD51. More than a third of molecules anal-
ysed failed to adopt a compact conformation and retained
the flexible extended conformation. The residue F1524 is
the phenylalanine of the FxxA motif of Brc 4 and muta-
tion of phenylalanine at 1524 to valine, most likely dis-
rupts hydrophobic interaction with RAD51 (9). This sug-
gests that interaction with RAD51 and the Brc 4 is cru-
cial for the dynamic allosteric interactions resulting in the
compact BRCA2-RAD51 conformation. The observed va-
riety of conformations is indicative of multiple energetically
equivalent conformations in BRCA2, one or more of which
is not able to interact with RAD51 when phenylalanine
1524 is replaced by a valine.
Given that all the regions of BRCA2 can interact with
RAD51 and undergo a conformational change, it is intrigu-
ing to speculate how these interactions could contribute to
BRCA2 function. Multivalent interaction of BRCA2 with
RAD51 may be spatio-temporally decoupled such that they
contribute to different functions of BRCA2. Distinct func-
tional profiles of the Brc–RAD51 interaction and CDK1/2
phosphorylation dependent interaction of the C-terminal
RAD51 binding site at S3291 have been suggested previ-
ously (10–12,15,16,39). Broadly, while interaction with the
Brc repeats allows BRCA2 to carry RAD51 to the site of
DNA damage, the C-terminal interaction appears to be reg-
ulatory in nature. It is thus likely that the N-terminal in-
teractions are also modulatory in function, conditions of
which need to be explored further.
BRCA2 is a complex protein comprising multiple IDRs
interspersed throughout 3418 aa. Proteins with significant
amounts of IDRs are characterized by flexible backbones
that allow sampling numerous energetically equivalent con-
formations, thereby giving rise to an ensemble of function-
ally competent conformations. Multi-valency coupled with
dynamic allostery can function as a dynamic switch, in re-
sponse to micro-environment changes and interacting part-
ners, to orchestrate complex molecular functions without
needing high energy co-factors (2,37,40–44). BRCA2 is a
hub for interactions among proteins involved in homolo-
gous recombination, in the centre of a dynamic functional
landscape. Here, we begin to define BRCA2’s conforma-
tional landscape, as a step to determine how this facilitates
essential molecular hand-off reactions in genome mainte-
nance.
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